Kayla is an Australian-qualified associate in the Private Equity group.
She advises private equity houses, and their portfolio companies and management teams, on UK and cross-border acquisitions, disposals and restructurings across a range of industry sectors. Kayla also advises corporate clients on mergers & acquisitions and general corporate matters.
Wir haben den CEO und das Managementteam von Synthon, einem globalen Pharmaunternehmen mit Schwerpunkt auf Generika, bei dessen Verkauf durch BC Partners an Goldman Sachs Alternatives (Goldman Sachs) beraten.
PressemitteilungWe have advised Sullivan Street Partners, a UK-based mid-market buy-out specialist, on its sale of grounds maintenance company Tivoli to the Nurture Group.
Press releaseWe have advised Sullivan Street Partners, a UK-based mid-market buy-out specialist, on its acquisition of UK Addiction Treatment Group (UKAT), the UK’s leading, residential addiction treatment group.
Press releaseWe have advised Coherent Corp., the global leader in materials, networking, and lasers, on selling its manufacturing site in Newton Aycliffe, County Durham, UK to the UK Government.
Press releaseWe have advised Inflexion on its investment into FDMUK Limited, a provider of telecoms market share, pricing and proposition data across Europe.
Press releaseWe have advised the management team of Chambers and Partners on the sale of Inflexion's investment in the firm to Abry Partners, a leading middle market private equity firm headquartered in North America.
Press release
von mehreren Autoren
Advising Inflexion on its investment into FDMUK Limited
von mehreren Autoren
Taylor Wessing advises in Inflexion's £400 million sale of Chambers to Abry Partners
von mehreren Autoren
von mehreren Autoren
von mehreren Autoren
von mehreren Autoren
von mehreren Autoren
von mehreren Autoren
von mehreren Autoren
von mehreren Autoren
von Andrew Edge und Lucinda Hicks